Initial Reports (BUY, SPEC BUY Ratings)
Microsoft Corp. (MSFT:NASDAQ)
Microsoft (MSFT:NASDAQ) is one of the largest consumer and enterprise software companies in the world. Known for its Windows operating system and Office productivity suite, Microsoft has also become a major player in the cloud computing space which helped influence us to recommend the company in January 2019 at a price of $105.08. Showing strength in all of its business segments and trading at reasonable valuation multiple, Microsoft’s share price has since performed well for our clients – increasing over 100% (including dividends) in under a year.
Zynex Inc. (ZYXI:NASDAQ)
In late 2017, KeyStone’s analysts uncovered Zynex Inc., a small-cap electrotherapy medical device company then trading on the U.S. OTC market at a price of $3.00 per share. Just prior to our initial recommendation we uncovered that Zynex’s largest competitor in the electrotherapy market had ceased to operate, offering Zynex the opportunity to dominate its market. During this time the company was able to grow its revenues at a rapid pace, had recently broke into profitability, was trading at attractive valuation multiples – leading to the company uplisting from the OTC exchange to the NASDAQ. Providing our clients with tremendous gains into 2019 and beyond.
EPAM Systems Inc. (EPAM:NYSE)
EPAM is a leading global digital and product design agency that KeyStone initially recommended to clients in late 2018 at a price of $123.28. Our analysts saw an opportunity within EPAM’s software engineering expertise and the rapidly growing areas of artificial intelligence and data analytics. Along with an impressive track record of organic growth, consistent profitability, a cash rich balance sheet and reasonable valuation multiples. These key drivers along with further operational execution by management caused the share price to soar and provided clients with a return of over 170%.